adverse effe Archives

FDA Approves Myrbetriq to Treat Pediatric NDO

03/04/2021 adverse effe, angioneurotic edema, antigens, biologic therapy, bladder infection, Child, childhood, children, FDA, headache, hypertension, increased blood pressure, kids, oab (overactive bladder), overactive bladder (oab), pediatrics, Spinal cord injury, u.s. food and drug administration, united states food and drug administration, urinary frequency, Urinary Tract Infection, urinary tract infection (uti), UTI

The US Food and Drug Administration (FDA) has expanded the indication for Mirabegron (Myrbetriq/Myrbetriq Granules) to treat neurogenic detrusor overactivity